CD8A and cancer: Although intratumoral CD8 T cells are key players in controlling cancer progression, different counteracting mechanisms, including tumor antigen loss, reduced antigen presentation, and especially induction of T cell exhaustion, can limit their efficacy, leading to immune evasion [20].